Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-14

FDA Approved: MESALAMINE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approves the original Abbreviated New Drug Application for Mesalamine from Rising Pharma Holdings, Inc., establishing a generic version of the medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

ORIG AP for MESALAMINE (MESALAMINE)